T and B cell responses to multivalent prime-boost DNA and viral vectors vaccine combinations against Hepatitis C virus in non-human primates

T and B cell responses to multivalent prime-boost DNA and viral vectors vaccine combinations against Hepatitis C virus in non-human primates

Immune responses against multiple epitopes are required for the prevention of Hepatitis C Virus infection, and the progression to Phase I trials of candidates may be guided by comparative immunogenicity studies in non-human primates. Four vectors, DNA, SFV, human serotype 5 adenovirus (HuAd5) and Mo...

Full description

Bibliographic Details
Main Authors:	Rollier, C, Verschoor, E, Verstrepen, B, Drexhage, J, Paranhos-Baccala, G, Liljeström, P, Sutter, G, Arribillaga, L, Lasarte, J, Bartosch, B, Cosset, F, Inchauspe, G, Heeney, J
Format:	Journal article
Published:	Nature Publishing Group 2016

Similar Items

Modulation of vaccine-induced immune responses to hepatitis C virus in rhesus macaques by altering priming before adenovirus boosting.
by: Rollier, C, et al.
Published: (2005)

Vaccination of chimpanzees with a multicomponent DNA-protein prime-boost regimen provides an enhanced recovery following heterologous HCV challenge.
by: Heeney, J, et al.
Published: (2001)

Chronic hepatitis C virus infection established and maintained in chimpanzees independent of dendritic cell impairment.
by: Rollier, C, et al.
Published: (2003)

Clearance of genotype 1b hepatitis C virus in chimpanzees in the presence of vaccine-induced E1-neutralizing antibodies.
by: Verstrepen, B, et al.
Published: (2011)

Vaccine-induced early control of hepatitis C virus infection in chimpanzees fails to impact on hepatic PD-1 and chronicity.
by: Rollier, C, et al.
Published: (2007)

Control of heterologous hepatitis C virus infection in chimpanzees is associated with the quality of vaccine-induced peripheral T-helper immune response.
by: Rollier, C, et al.
Published: (2004)

Improved HIV-1 specific T-cell responses by short-interval DNA tattooing as compared to intramuscular immunization in non-human primates.
by: Verstrepen, B, et al.
Published: (2008)

Improved HIV-1 specific T-cell responses by short-interval DNA tattooing as compared to intramuscular immunization in non-human primates
by: Verstrepen, B, et al.
Published: (2008)

Ebola-GP DNA Prime rAd5-GP Boost: Influence of Prime Frequency and Prime/Boost Time Interval on the Immune Response in Non-human Primates
by: Hadar Marcus, et al.
Published: (2021-03-01)

Immunogenicity of Low-Dose Prime-Boost Vaccination of mRNA Vaccine CV07050101 in Non-Human Primates
by: Neeltje van Doremalen, et al.
Published: (2021-08-01)

Macaques primed with self-amplifying RNA vaccines expressing HIV-1 envelope and boosted with recombinant protein show potent T- and B-cell responses
by: Bogers WM, et al.
Published: (2012-09-01)

Immune responses against a liver-stage malaria antigen induced by simian adenoviral vector AdCh63 and MVA prime-boost immunisation in non-human primates
by: Capone, S, et al.
Published: (2010)

Immune responses against a liver-stage malaria antigen induced by simian adenoviral vector AdCh63 and MVA prime-boost immunisation in non-human primates.
by: Capone, S, et al.
Published: (2010)

Competition between CTL narrows the immune response induced by prime-boost vaccination protocols.
by: Palmowski, M, et al.
Published: (2002)

Construction and immunogenicity in a prime-boost regimen of a Semliki Forest virus-vectored experimental HIV clade A vaccine.
by: Hanke, T, et al.
Published: (2003)

Upregulation of indoleamine 2,3-dioxygenase in hepatitis C virus infection.
by: Larrea, E, et al.
Published: (2007)

Immunogenicity and protectivity of intranasally delivered vector-based heterologous prime-boost COVID-19 vaccine Sputnik V in mice and non-human primates
by: Amir I. Tukhvatulin, et al.
Published: (2022-12-01)

Qualitative differences in cellular immunogenicity elicited by hepatitis C virus T-Cell vaccines employing prime-boost regimens.
by: Wendy G Tan, et al.
Published: (2017-01-01)

Subclasses Of Multivalent Harmonic Mappings Defined By Convolution.
by: Ali, R. M., et al.
Published: (2009)

Modeling the effect of boost timing in murine irradiated sporozoite prime-boost vaccines.
by: Cristina Fernandez-Arias, et al.
Published: (2018-01-01)

Alphavirus replicon DNA expressing HIV antigens is an excellent prime for boosting with recombinant modified vaccinia Ankara (MVA) or with HIV gp140 protein antigen.
by: Maria L Knudsen, et al.
Published: (2015-01-01)

Priming with DNA encoding functional trimers and boosting with soluble trimeric protein elicited tier 2 neutralizing antibodies in non-human primates
by: Chakrabarti BK, et al.
Published: (2012-09-01)

Heterologous prime-boost vaccination protects against EBV antigen-expressing lymphomas.
by: Rühl, J, et al.
Published: (2019)

Prime-boost immunisation strategies for tuberculosis.
by: Mcshane, H, et al.
Published: (2005)

Prime-boost vectored malaria vaccines: progress and prospects.
by: Hill, A, et al.
Published: (2010)

Resolution of Eczema with Multivalent Peptides
by: Laura L. Eggink, et al.
Published: (2022-09-01)

Nanoscale Peptide Self-assemblies Boost BCG-primed Cellular Immunity Against Mycobacterium tuberculosis
by: Charles B. Chesson, et al.
Published: (2018-08-01)

rAd5 prime/NYVAC-B boost regimen is superior to NYVAC-B prime/rAd5 boost regimen for both response rates and magnitude of CD4 and CD8 T-cell responses
by: Bart P, et al.
Published: (2012-09-01)

Multivalent functions/
by: 340548 Hayman, Walter Kurt
Published: (1958)

Parainfluenza Virus 5 Priming Followed by SIV/HIV Virus-Like-Particle Boosting Induces Potent and Durable Immune Responses in Nonhuman Primates
by: Peng Xiao, et al.
Published: (2021-02-01)

Prime-boost regimen potency and efficacy with alphavirus replicons (SIV antigen) in non-human primates challenged with low-dose intra-rectal SIVsmE660
by: Banerjee K, et al.
Published: (2012-09-01)

Multi-component prime-boost Chlamydia trachomatis vaccination regimes induce antibody and T cell responses and accelerate clearance of infection in a non-human primate model
by: Emma Lorenzen, et al.
Published: (2022-11-01)

P19-58 LB. Comparison of the immunogenicity in humans and rhesus macaques of vaccines consisting of DNA priming and MVA boosting and MVA priming and boosting
by: Wyatt LS, et al.
Published: (2009-10-01)

Proof of concept in non-human primates of the heterologous prime-boost strategy combining dengue-2 virus and recombinant proteins including domain III of the viral envelope protein
by: Iris Valdés, et al.

Factoring semi-primes with (quantum) SAT-solvers
by: Michele Mosca, et al.
Published: (2022-05-01)

Prime-boost strategies for malaria vaccine development.
by: Dunachie, S, et al.
Published: (2003)

Prime-boost immunization strategies for infectious diseases.
by: Mcshane, H
Published: (2002)

Pinpointing the PRDM9-PRDM7 Gene Duplication Event During Primate Divergence
by: Sacha Heerschop, et al.
Published: (2021-02-01)

Serological Detection of Ebola Virus Exposures in Native Non-human Primates of Southern Nigeria
by: B.N. Ogunro, et al.
Published: (2018-12-01)

Multivalent glycosystems for nanoscience
by: Thisbe K. Lindhorst
Published: (2014-10-01)